TAAR1 and Alzheimer disease: In summary, we provided, for the first-time, preliminary evidence that the T1AM/TAAR1 signaling pathway has the potential to normalize factors that regulate microglia-mediated neuroinflammation, further increasing the relevance of this system in the pathophysiology of aging-related brain diseases like AD.